Last $165.31 USD
Change Today +0.59 / 0.36%
Volume 1.8M
AMGN On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Judith C. Pelham

Director, Member of Audit Committee and Member of Compensation & Management Development Committee, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 3 different organizations across 6 different industries.

See Board Relationships
68$345,274

Background*

Ms. Judith C. Pelham, also known as Judy, served as the Chief Executive Officer and President of Daughters of Charity Health Services of Austin, Inc., from 1982 to 1992 and Trinity Health Corporation from May 2000 to December 2004. For more than 20 years, Ms. Pelhamhas been a leader and recognized pioneer in developing programs to improve the health status of communities, particularly for the poor and underserved. With the expressed goal of creating the health system ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

1995-Present
Director, Member of Audit Committee and Member of Compensation & Management Development Committee
2005-2006
Former Director and Member of Audit & Public Policy Committee
2009-2010
Former Director and Member of Compensation Committee
2011-Present
Director and Member of Compensation Committee
2012-Present
Director, Member of Compensation Committee, Member of Planning Committee, Member of Investment Committee and Member of Nominating/Corporate Governance Committee

Education*

BA 1967
Smith College
Master's Degree 1975
Harvard University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$145,313
Total Calculated Compensation$345,274
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMGN:US $165.31 USD +0.59

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.